SIS contributes to safer, cheaper and more sustainable medical technology

By working with standards, increased patient safety is ensured. The standards also contribute to societal the benefits and an improved working environment for healthcare personnel. SIS is appointed by the Swedish government to develop standards and represent Sweden in the international standardization arena. 

Future of Health: Advanced Therapy Medicinal Products (ATMP)

-

Advanced Therapy Medicinal Products are biological pharmaceuticals based on cells, tissue, or genes. These pharmaceuticals are considered to be a very important part of future healthcare. Often it’s a one-time treatment where seriously ill patients are can be cured, hopefully with a lifelong effect. During this panel discussion we will talk about where we stand today, which challenges remain to be solved and what the future opportunities are.

New tools to explore disease mechanisms and facilitate drug development

-

Seminari: In order to understand disease mechanisms and how drugs interact with their target proteins, new tools are under constant development. Advancements in protein science have provided new novel methods for better understanding of human biology, improved diagnostics and more effective drug delivery.

Subscribe to